Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 21:14:1106.
doi: 10.3332/ecancer.2020.1106. eCollection 2020.

Antibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature

Moises S Martins Lopes  1 , Larissa M Machado  1 , Pedro A Ismael Amaral Silva  1 , Angel A Tome Uchiyama  1 , Cheng T Yen  1 , Eliza D Ricardo  1 , Taciana S Mutao  1 , Jefferson R Pimenta  1 , Denis S Shimba  1 , Rodrigo M Hanriot  1 , Renata D Peixoto  2
Affiliations
Review

Antibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature

Moises S Martins Lopes et al. Ecancermedicalscience. .

Abstract

Antibiotics have been extensively used to treat infectious diseases over the past century and have largely contributed to increased life expectancy over time. However, antibiotic use can impose profound and protracted changes to the diversity of the microbial ecosystem, affecting the composition of up to 30% of the bacterial species in the gut microbiome. By modifying human microbiota composition, antibiotics alter the action of several oncologic drugs, potentially leading to decreased efficacy and increased toxicities. Whether antibiotics interfere with cancer therapies or even increase the risk of cancer development has been under investigation, and no randomised trials have been conducted so far. The aim of the current review is to describe the possible effects of antibiotic therapies on different oncologic treatments, especially immunotherapies, and to explore the link between previous antibiotics use and the development of cancer.

Keywords: antibiotics; cancer; chemotherapy; immunotherapy; microbiome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. National Centre for Health Statistics. [05/02/20]. [ https:www.cdc.gov/nchs/fastats/life-expectancy.htm]
    1. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ. Br J Exp Pathol. 1929;10(3):226–236.
    1. Klein EY, Levin SA, Laxminarayan R. Reply to Abat et al.: Improved policies necessary to ensure an effective future for antibiotics. Proc Natl Acad Sci. 2018;115(35):E8111–E8112. doi: 10.1073/pnas.1811245115. - DOI - PMC - PubMed
    1. Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science. 2016;352(6285):544–545. doi: 10.1126/science.aad9358. - DOI - PMC - PubMed
    1. Bp W, Sl R, Bb F. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol. 2011;9(4):233–243. doi: 10.1038/nrmicro2536. - DOI - PubMed

LinkOut - more resources